Provisional Agenda
(Subject to change: The conference may finish earlier or later than the advertised time)
Event type: Virtual/in-person hybrid
Presentation language: English
Venue: The Jarvis Doctorow Hall, St Edmund Hall, Queen’s Lane, Oxford, UK
Time Zone: All times mentioned refer to British Standard (BST) – London/GMT +01:00.
Password and links: Registered conference delegates will be sent joining information and conference access links a few days before the conference.
World Time Converter: https://greenwichmeantime.com/time-gadgets/time-zone-converter | https://greenwichmeantime.com/timepiece/world-clock | https://www.worldtimebuddy.com
NB: Due to the hybrid nature of the agenda and the wide geographical locations of our speakers, it may not always be possible to group related presentations together.
Day 1, 26th August
1330: Registration
1425: Welcome and housekeeping
Inaugural keynote
1430: Dr David Williams
Consultant, Regulation and Prequalification Department, Health Systems Division, World Health Organization, Geneva CH
The road less travelled: why it is important to study snakebite in the places where it happens
Session 1: Part A – Snakebite: diagnosis, and clinical treatment
1500: Professor Sir David Warrell
Professor, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Snakebite species identification threatened by inexpert practice
1520: Professor Juan Calvete, Instituto de Biomedicina de Valencia, Spain
Separating the wheat from the chaff: deconstructing venoms to construct antivenoms
1540: Dr Tihana Kurtović
Postdoctoral Researcher, Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Rockefellerova, Zagreb, Croatia
One antivenom, two paths: which administration route wins against venom?
1600: Refreshment break, poster viewing and networking
1630: Dr Tatiana Djikeussi
Principal Investigator, Premium Serums & Vaccines Pvt Ltd (PSVPL), Cameroon
A Post-Marketing Study on Safety and Efficacy of PANAF-Premium™ for Snakebite Envenomation in Northern Cameroon
Session 1: Part B – Snakebite: Novel antivenom development
1650: Dr Anne Ljungars
Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark
Oligoclonal nanobody-based recombinant antivenom for cobra, mamba, and rinkhals bites
1710: Dr Sheikh Mohammed Arif
Postdoctoral Researcher, Department of Medicine, University of Cambridge, Addenbrookes Hospital, Hills Rd, Cambridge, UK
Generating novel recombinant monoclonal antibodies targeting phospholipase A2 from spitting cobras
1730: End of Day 1
Day 2, 27th August
Session 2: The pathophysiological effects of venom
0930: Dr Charlotte Dawson
Postdoctoral Researcher, Centre for Inflammation Research, Institute of Regeneration and Repair, University of Edinburgh, Edinburgh, UK
Establishing a preclinical chronic wound model to characterise the pathophysiology of snakebite envenoming
0950: Dr Krisna Prak
Postdoctoral Researcher, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK
Snake venom L-amino acid oxidase induces mitochondria and lysosomal dysfunctions preventing autophagic flux and organelle clearance
1010: Miss Alexandra Sundman
Graduate Research Student, Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD, Australia
Structure and mechanism of action of the lethal phospholipase D toxin from recluse spiders
1030: Dr Rebecca Edge
Postdoctoral Researcher, Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
The design and expression of a functional consensus P-I snake venom metalloproteinase
1050: Refreshment break, poster viewing and networking
1120: Lifetime Achievement Award presentation – to be presented by Professors Calvete and Warrell
Recipient: Dr David Williams
Session 3: Venom variation: causes and consequences
1150: Professor Solange Serrano
Professor, Laboratory of Applied Toxinology, Center of Toxins, Immune-Response, and Cell Signaling (CeTICS), Butantan Institute, São Paulo, Brazil
Snake venom omics analyses: sharpening the understanding of various layers of complexity
1210: Professor Ana Maria Moura da Silva
Professor, Laboratório de Imunopatologia, Instituto Butantan, São Paulo, Brazil
Phenotypic dichotomy in Crotalus durissus ruruima venom and potential consequences for clinical management of snakebite envenomations
1230: Mr Lee Jones
Graduate Research Student, Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St Lucia, QLD, Australia
Ontogenetic variation in coagulotoxic activity and antivenom efficacy of Central American pit viper venoms (Cerrophidion, Metlapilcoatlus, Ophryacus and Porthidium)
1250: Lunch, poster viewing and networking
1400: Panel discussion – Confronting the Snakebite Crisis with Science and System (TBC)
Session 4: Translational venom research
1500: Professor Glenn King
Professor, Institute for Molecular Bioscience, The University of Queensland, B risbane QLD, Australia
Deadly cures: a venom-inspired drug candidate for heart attack and heart transplantation
1520: Dr David Eagles
Postdoctoral Researcher, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
Development of a tarantula venom-derived peptide into a therapeutic for irritable bowel syndrome
1540: Refreshment break, poster viewing and networking
Session 5: Virtual presentations
1600: Professor Naoual Oukkache
Principal Investigator, Pasteur Institute of Morocco, Morocco
Development of humanized nanobodies targeting Naja haje neurotoxins: a promising complementary therapy for cobra envenomation
1620: Dr Sebastien Duterte
Group Leader, University of Montpellier, France
Predatory vs defensive venom uses in cone snails: who cares, say the snakes
1640: Professor Helena Safavi-Hemami
Professor, Department of Biochemistry and School of Biological Sciences, University of Utah, Salt Lake City, UT
Molecular mimicry: ecology, evolution, and applications of doppelgänger peptides from cone snail venom
1700: Professor José María Gutiérrez
Professor, Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
A murine experimental model of the unique thrombotic effect induced by the venom of Bothrops lanceolatus
1720: Dr Susana Vazquez Torres
Postdoctoral Researcher, Department of Biochemistry, University of Washington, Seattle, WA, USA
De novo designed proteins neutralize lethal snake venom toxins
1740: End of Day 2
1900: Networking dinner (further information to follow by email)
Day 3, 28th August
Session 6: Beyond snakebite: Bacterial, scorpion and cnidarian toxins
0920: Professor Andreas Laustsen
Professor, Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, ongens Lyngby, Denmark
Protecting the human gut microbiota against pathogenic bacteria by neutralizing toxins and virulence factors with specific binding proteins
0940: Mr Sam Campbell
Graduate Research Student, Adaptive Biotoxicology laboratory, School of the Environment, The University of Queensland, Brisbane, Australia
Electrophysiological investigation of the relative efficacy of three antivenoms against medically significant Centruroides species
1000: Miss Tian Du
Graduate Research Student, Charles Perkins Centre, The University of Sydney, NSW, Australia
A broad acting cnidaria venom antidote identified through whole genome CRISPR Screening
1020: Miss Claire Ittleson
School of Biological Sciences, University of Bristol, Bristol, BS8 1TQ, UK
Stony coral toxins in the face of climate change
1040: Refreshment break, poster viewing and networking
Session 7: Methodologies
1110: Professor Cesare Montecucco
Professor Emeritus, Department of Biomedical Sciences, University of Padova and Institute of Neuroscience, National Research Council, Padova, Italy
Novel and simple methods to evaluate quantitatively respiration and peripheral neuroparalysis in mice poisoned by neurotoxic snake venoms without any animal manipulation
1130: Dr Charlotte Whitmore
Toxicology delivery Team, Human & Biological Advantage, Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire, UK
Toxin activity assays: applications for defence and security science
1150: Dr Loïc Quinton
Mass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 – Quartier Agora, 4000, Liège, Belgium
Affinity-Capture Mass Spectrometry for the Discovery of Receptor-Targeting Peptides in Animal Venoms
1210: Miss Imène Ayaden
CiTCoM UMR CNRS 8038, Faculty of pharmacy of Paris, Paris Cité University, Paris, France
Development of an electrochemical model for the detection and evaluation of the potential toxicity of naturally occurring furanic compounds
1220-1240: General discussion, networking and departure
